B

BioMark Diagnostics Inc
SWB:20B

Watchlist Manager
BioMark Diagnostics Inc
SWB:20B
Watchlist
Price: 0.193 EUR 12.21% Market Closed
Market Cap: 17.5m EUR

Intrinsic Value

20B's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one 20B stock under the Base Case scenario is 0.004 EUR. Compared to the current market price of 0.193 EUR, BioMark Diagnostics Inc is Overvalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

20B Intrinsic Value
0.004 EUR
Overvaluation 98%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case
Compare 20B to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BUX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about BioMark Diagnostics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioMark Diagnostics Inc

Current Assets 159.4k
Cash & Short-Term Investments 88.6k
Receivables 70.8k
Non-Current Assets 717.2k
Long-Term Investments 3.2k
PP&E 679.9k
Other Non-Current Assets 34.1k
Efficiency

Free Cash Flow Analysis
BioMark Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioMark Diagnostics Inc

Revenue
155k CAD
Operating Expenses
-2.1m CAD
Operating Income
-2m CAD
Other Expenses
56.3k CAD
Net Income
-1.9m CAD
Fundamental Scores

20B Profitability Score
Profitability Due Diligence

BioMark Diagnostics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

40/100
Profitability
Score

BioMark Diagnostics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

20B Solvency Score
Solvency Due Diligence

BioMark Diagnostics Inc's solvency score is 20/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
20/100
Solvency
Score

BioMark Diagnostics Inc's solvency score is 20/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

20B Price Targets Summary
BioMark Diagnostics Inc

There are no price targets for 20B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

BioMark Diagnostics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BUX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one 20B stock?

The intrinsic value of one 20B stock under the Base Case scenario is 0.004 EUR.

Is 20B stock undervalued or overvalued?

Compared to the current market price of 0.193 EUR, BioMark Diagnostics Inc is Overvalued by 98%.

Back to Top